NEUROCRINE BIOSCIENCES INC (NBIX) Stock Income Statement
NASDAQ:NBIX - Nasdaq - US64125C1099 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.41B | 2.36B | 1.89B | 1.49B | 1.13B | |||
| Cost Of Goods | 35.70M | 34.00M | 39.70M | 23.20M | 14.30M | |||
| Gross Profit | 2.38B | 2.32B | 1.85B | 1.47B | 1.12B | |||
| Operating Expenses | 1.88B | 1.74B | 1.45B | 1.21B | 911.40M | |||
| Research and Development | 834.90M | 731.10M | 565.00M | 463.80M | 328.10M | |||
| Selling, General, and Administrative Expenses | 1.04B | 1.01B | 887.60M | 751.00M | 583.30M | |||
| Operating Income | 501.40M | 583.00M | 394.80M | 250.70M | 207.80M | |||
| Interest Income/Expense | -28.60M | -84.50M | 81.20M | 34.90M | -1.10M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | -6.60M | -12.50M | -143.90M | -71.70M | -105.30M | |||
| Income Before Taxes | 466.20M | 486.00M | 332.10M | 213.90M | 101.40M | |||
| Income Tax | 160.40M | 144.70M | 82.40M | 59.40M | 11.80M | |||
| Net Income | 305.80M | 341.30M | 249.70M | 154.50M | 89.60M | |||
| EBITDA | 529.90M | 610.10M | 416.10M | 266.30M | 218.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.95 | 3.29 | 2.47 | 1.56 | 0.92 | |||
| Non GAAP EPS | 2.95 | 3.29 | 2.42 | 1.53 | 1.32 | |||
| Statistics | ||||||||
| Gross Profit Margin | 98.52% | 98.56% | 97.90% | 98.44% | 98.74% | |||
| Profit Margin | 12.68% | 14.49% | 13.23% | 10.38% | 7.90% | |||
| Operating Profit Margin | 20.78% | 24.75% | 20.92% | 16.84% | 18.33% | |||
All data in USD